TY - JOUR
T1 - Emerging issues in adult female acne
AU - Zeichner, Joshua A.
AU - Baldwin, Hillary E.
AU - Cook-Bolden, Fran E.
AU - Eichenfield, Lawrence F.
AU - Fallon-Friedlander, Sheila
AU - Rodriguez, David A.
N1 - Publisher Copyright:
© 2014 Celgene Corporation, All rights Reserved.
PY - 2017/1
Y1 - 2017/1
N2 - Acne vulgaris (acne) is a common affliction in adolescence and is a growing problem in adult women. Despite an increasing awareness of acne in the adult female population, there is a lack of good prospective studies assessing the severity, distribution, and diAerential response to treatment in this group. The long-held dogma that acne in adult women develops on the lower onethird of the face has been recently challenged, and here the authors critically review data from available literature. Moreover, while adult female acne has traditionally been defined as disease in women over age 25, it is the authors' experience that this group is subdivided into women ages 25 to 44 years, separate from perimenopausal patients, ages 45 years and up. while there is no data specifically comparing these two groups, the authors will review the existing data and provide practical recommendations based on our experience in treating these groups of patients. Finally, while there is a lack of data on this subject, it is the group's opinion that adherence to medication regimens is likely higher in women than men, which inDuences therapeutic outcomes.
AB - Acne vulgaris (acne) is a common affliction in adolescence and is a growing problem in adult women. Despite an increasing awareness of acne in the adult female population, there is a lack of good prospective studies assessing the severity, distribution, and diAerential response to treatment in this group. The long-held dogma that acne in adult women develops on the lower onethird of the face has been recently challenged, and here the authors critically review data from available literature. Moreover, while adult female acne has traditionally been defined as disease in women over age 25, it is the authors' experience that this group is subdivided into women ages 25 to 44 years, separate from perimenopausal patients, ages 45 years and up. while there is no data specifically comparing these two groups, the authors will review the existing data and provide practical recommendations based on our experience in treating these groups of patients. Finally, while there is a lack of data on this subject, it is the group's opinion that adherence to medication regimens is likely higher in women than men, which inDuences therapeutic outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85010430846&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:85010430846
SN - 1941-2789
VL - 10
SP - 37
EP - 46
JO - Journal of Clinical and Aesthetic Dermatology
JF - Journal of Clinical and Aesthetic Dermatology
IS - 1
ER -